Merck & Co., Inc.: Amended and restated by-laws to revise and update indemnification provisions, with other non-substantive and conforming revisions (effective 2024-11-19).
Change
bylaw amendment
Effective
2024-11-19
Exact text from the filing
On November 19, 2024, the Board approved and adopted amended and restated by-laws of the Company (as so amended and restated, the "By-Laws"), effective as of such date. The amendments to the By-Laws revise and update the indemnification provisions applicable to the Company's directors, officers, employees and agents.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.